Assessing Rubella Immunity: Seroprevalence among Pregnant Women in Brazzaville, Congo

Authors

  • Mieret Tanguy

  • Ontsira Ngoyi E.N.

  • Aloumba A.

  • Doumbia M.

  • Ossibi Ibara B. R.

  • Faye-Kette H.

DOI:

https://doi.org/10.34257/GJMRCVOL24IS1PG45

Keywords:

pregnant women, rubella, seroprevalence

Abstract

Background Rubella constitutes an important public health problem due to the potential teratogenic effect of the virus when infection occurs early in pregnancy The objective of this study was to determine the rubella serological profile of pregnant women Methodology We conducted a prospective cross-sectional study from January 1 to March 31 2022 a period of 3 months Venous blood samples from 98 pregnant women who came for biological investigations to the laboratory of the Blanche Gomez Specialized Mother-Child Hospital Brazzaville Congo were analyzed The determination of immunoglobulins G and M was carried out on the Architect i1000SR analyzer ABBOTT using the chemiluminescence immunological technique

Downloads

How to Cite

Mieret Tanguy, Ontsira Ngoyi E.N., Aloumba A., Doumbia M., Ossibi Ibara B. R., & Faye-Kette H. (2025). Assessing Rubella Immunity: Seroprevalence among Pregnant Women in Brazzaville, Congo. Global Journal of Medical Research, 24(C1), 45–51. https://doi.org/10.34257/GJMRCVOL24IS1PG45

 
Assessing Rubella Immunity: Seroprevalence among Pregnant Women in Brazzaville, Congo

Published

2025-01-09

Issue

Vol. 24 No. C1 (2024): GJMR-C Microbiology & Pathology: Volume 24 Issue C1

Section

Articles

License

Copyright (c) 2024 Authors and Global Journals Private Limited

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.